RTOG 0913: A phase I study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Prakash Chinnaiyan
Research Funding - Merck
Minhee Won
No relevant relationships to disclose
Patrick Y. Wen
Honoraria - Merck
Research Funding - Merck
Amyn Rojiani
No relevant relationships to disclose
Merideth M Wendland
No relevant relationships to disclose
Thomas A. DiPetrillo
No relevant relationships to disclose
Benjamin W. Corn
No relevant relationships to disclose
Minesh P. Mehta
Consultant or Advisory Role - Merck; Roche
Honoraria - Merck